Global Immunomodulator Market to be Aided by the Surging Incidence of Chronic Diseases Among the Geriatric Population

The global immunomodulator industry is dominated by the North America region. Immunomodulator are used to regulate the immunity system. They alter the reaction of the immune system by changing the production of antibody cells. Diseases such as asthma, cancer, allergic conditions, sclerosis, Crohn’s disease and ulcerative colitis, among others, increases the demand for end-users immunomodulator-based treatment and high therapy cost associated with treatments are anticipated to drive revenue growth in the market. Factors contributing to the growth of immunomodulator market include infectious diseases primarily considered immunological disorders, organ transplantation, increasing adoption of an early immunomodulator therapy, rising awareness about inflammatory bowel diseases, growing autoimmune disease, and the increasing development of drug resistance resulting in rise of immunomodulatory usage. There are lucrative opportunities for the immunomodulator industry in developing nations due to unfulfilled clinical needs and lack of healthcare service delivery. Government is taking initiatives to increase awareness among the public regarding the benefits of immunomodulators.

Immunomodulators are becoming a viable adjunct to established modalities offering a completely unique approach for the treatment of communicable disease within the coming decades of 21st century. However, some drugs can cause fatigue, drowsiness, blood clotting and low blood pressure, amongst others. It can cause several birth defects, if consumed during gestation. The COVID-19 positively impacted the growth of immunomodulator market in the historical period. Due to outflow in the sale of emergency products, pharmaceutical companies are trying to maintain their supply chain, investing more in research and development, quality control, supply chain and operations management, fuelling the growth of the immunomodulator industry.

The rising competition among the key players is also providing an impetus to the market growth. In September 2021, Abbott Laboratories (NYSE: ABT) announced the acquisition of Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots. The acquisition fits well into their leading vascular device offerings and further drives Abbott's ability to provide one-of-a-kind endovascular therapy solutions to improve patient care.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis by Products, Applications, and Regions:

• Based on types, the industry can be divided into immunosuppressants and immunostimulants.

• On the basis of applications, the market can be divided into oncology, respiratory and HIV, amongst others.

• The regional markets for immunomodulators include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• Increase in the number of diseases and infections is driving the growth of the immunomodulator market.  

• Increasing population triggers the demand for more vaccines and antibodies, boosting the demand for immunomodulators.  

• Rising awareness among the public and initiatives by governments is fuelling the demand for immunomodulators.  

• The COVID-19 pandemic has been propelling the market growth as demand for immunomodulators has increased during this period.

Key Offerings of the report:

• The EMR report gives an overview of the global immunomodulator market for the periods (2018-2023) and (2024-2032). 

• The report also offers the historical (2018-2023) and forecasted (2024-2032) markets for the products, applications, and regions of immunomodulator.  

• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global immunomodulator industry are F. Hoffmann-La Roche Ltd., Amgen, Inc., Abbott Laboratories, Novartis AG, and Biogen Inc., amongst others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players. 

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging. 

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve. 

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790